Amit Bhalla - 15 Nov 2021 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Erika L. Eves for Amit Bhalla, by power of attorney
Issuer symbol
N/A
Transactions as of
15 Nov 2021
Net transactions value
+$30
Form type
4
Filing time
02 Dec 2021, 15:10:09 UTC
Previous filing
01 Oct 2021
Next filing
04 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAVB Common Stock Award $30 +30,000 +326% $0.001000* 39,195 15 Nov 2021 Direct F1
transaction NAVB Common Stock Award $0 +2,623 +6.7% $0.000000 41,818 15 Nov 2021 Direct F2, F4
transaction NAVB Common Stock Award $0 +1,250 +3% $0.000000 43,068 30 Nov 2021 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan which vest as to one-third on each of the first three anniversaries of the date of grant.
F2 Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of quarterly non-employee director fees.
F3 Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of monthly non-employee director fees.
F4 Issuance deferred at the request of the Reporting Person.